Biologic Monitoring

assessment

• Symptom improvement evaluation
• Quality of life measures
• Reduction in exacerbations
• Decrease in oral steroid use
• Improvement in lung function (if applicable)

markers

• Reduction in symptom frequency and severity
• Improved asthma control scores
• Fewer emergency visits
• Better quality of life indicators

frequency

Laboratory monitoring varies by specific biologic medication

common Tests

• Complete blood count (CBC)
• Liver function tests
• Kidney function tests
• Inflammatory markers when indicated

timing

Baseline labs before starting, then periodic monitoring as indicated

common

• Injection site reactions (redness, swelling, pain)
• Headaches
• Upper respiratory infections
• Allergic reactions (rare but serious)

serious

• Anaphylaxis (rare but requires immediate attention)
• Parasitic infections (for some biologics)
• Malignancy concerns (ongoing monitoring)
• Cardiovascular events (monitoring as indicated)

monitoring

• Regular assessment at each visit
• Patient education on recognizing symptoms
• Clear instructions on when to seek immediate care
• Documentation of all adverse events

importance

Biologic therapies require consistent administration for optimal effectiveness.

factors

• Injection frequency and schedule
• Cost and insurance coverage
• Injection technique and comfort
• Side effect management
• Patient understanding of benefits

support

• Injection training and technique review
• Administration schedule optimization
• Cost assistance programs when available
• Regular check-ins and support

tracking

• Review injection logs
• Assess refill patterns
• Identify barriers to adherence
• Provide ongoing education and support

frequency

• Every 3-6 months for stable patients
• More frequently during initial treatment period
• As needed for adverse events or concerns

components

• Response assessment
• Adverse event screening
• Laboratory monitoring as indicated
• Adherence review
• Injection technique check
• Treatment plan adjustments